Metabolic Syndrome in Type 2 Diabetes
Article Sidebar
Main Article Content
Abstract
Metabolic syndrome is a cluster of conditions related to insulin resistance, which increased risk of atherosclerosis and type 2 diabetes. This cross sectional study was conducted on 1171 type 2 diabetes in Lampang Hospital's out patients department using IDF Consensus 2005 and NCEP ATP III criteria for diagnosing metabolic syndrome. The prevalance of metabolic syndrome
was higher when diagnosed with NCEP ATP III criteria whan with IDF criteria ((80.79% vs 54.57% ,p<0.001). The metabolic syndrome was higher in woman for both diagnostic criteria (84.65% vs 72.18%, p<0.001,NCEP ATP III; 61.51% vs 39.12%, p<0.001, IDF). Abdominal obestity was found in 76.36% of women and 40.77% of men, while low HDL cholesterol was found in
68.81% and 47.93% of women and men respectively. The prevalance of hypertriglycerides was 56.19% in women and 58.68% in men. Meanwhile, hypertension was diagnosed in 61.88% of women and 63.09% of men. Higher prevalance of coronary disease was observed for the metabolic syndrome patients (NCEP ATP III,53 out of 56, p=0.005; IDF, 39 out of 56, p0.027). HbA1c was also higher for the metabolic syndrome, which increases risk of coronary artery disease; so comprehensive care was required for these patients to mitigate the risk.
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
บทความที่ส่งมาลงพิมพ์ต้องไม่เคยพิมพ์หรือกำลังได้รับการพิจารณาตีพิมพ์ในวารสารอื่น เนื้อหาในบทความต้องเป็นผลงานของผู้นิพนธ์เอง ไม่ได้ลอกเลียนหรือตัดทอนจากบทความอื่น โดยไม่ได้รับอนุญาตหรือไม่ได้อ้างอิงอย่างเหมาะสม การแก้ไขหรือให้ข้อมูลเพิ่มเติมแก่กองบรรณาธิการ จะต้องเสร็จสิ้นเป็นที่เรียบร้อยก่อนจะได้รับพิจารณาตีพิมพ์ และบทความที่ตีพิมพ์แล้วเป็นสมบัติ ของลำปางเวชสาร
References
Wilson PWF, Grundy SM. The metabolic syndrome : practical guide to origins and treatment : part 1. Circulation 2003;108:1422-55.
Lakka HM, Lakksonen DE, Lakka TA, Niskanen LK, Kumpasalo E, Tuomilehto J, Saloen JT. The metabolic syndrome and total and cardivascular disease motality in middle age men. JAMA 2002;288:2709-16.
Lempiainen P, Mykkaen L, Pyorala K, Laakso M, Kuusisto J. Insulin resistance syndrome predicts coronary heart disease events in elderly non-diabetic men. Circulation 1999;100:123-8.
Scuteri A, Najjar S, Morrel C, Lakatta E. The metabolic syndrome in older individuals : prevalance and prediction of cardivascular events. Diabetes Care 2005;28:882-7.
Reaven GM. Banting lecture 1988 : role of insulin resistance in human disease. Diabetes 1988;37:1595-1607.
Liese AD, Mayer-Davis EJ, Haffner SM. Development of the metabolic syndrome : an epidemiclogic
perspective. Epidemiol Rev 1998;20:157-72.
World Health Organization: Definition, Diagnosis, and Classification of Diabetes Mellitus and its Complications. Report of a WHO consultation. Geneva: World Health Org; 1999.
Expert Panel on the Detection, Evalution, and Treatment of High Blood Cholesterol in Sdults: Excutive summary of the Third Report of the National Cholesterol in Adults : Excutive summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evalution, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001;285:2486-97.
Grundy SM, Brewer HB Jr, Cleeman JI, Smith SC Jr, Lenfant C, National Heart Lung and Blood Institute, American Heart Association. Definition of metabolic syndrome : report of the National Heart, Lung, and Blood Institute/ American Heart Association conference on scientific issues realted to definition. Circulation 2004;109:433-8.
Alberti KGMM, Zimmet P, Shaw J, for the IDF Epidemiology Task Force Consesus Group. The metabolic syndrome- a new worldwide definition. Lance 2005;366:1059-62.
Ford ES, Giles WH. A comparison of the pervalence of the metabolic syndrome using two proposed definitions. Diabetes Care 2003;26:575-81.
Oh JY, Sung YA, Hong YS, Connor EB. Prevalence and factor analysis of metabolic sndrome in an urban Korean population.
Diabetes Care 2004;27:2027-32.
Nithiyanant W,For the Diabetes Study Group of Thailand. Metabolic syndrome, ischemic heart disease and strole in Thais with type 2 diabetess. Intern Med J Thai 2005;21(Suppl 2):84.
Ninomiya JK et al. Association of the metabolic syndrome with history of myocardial infraction and stroke in the Third National Health and Nutrition Examination Survey. Circulation 2004;109:42-6.
Alexander CM, Lansman PB, Teutsch SM, Haffner SM. NCEP-defined metabolic sysdrome, diabetes, and prevalence of coronary heart disease among NHANES III participations age 50 years and older. Diabetes 2003;52:1210-4.
Chocanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JLT, et al. National Heart Lung and Blood Institute, Joint National Committe on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure Education Program Coordination Committee. The Seventh Report of the National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure.
JAMA 2003;289:2560-72.
Pinitphol S, Bunnag P. Metabolic syndrome in type 2 diabetic patients at Chainat Hospital. Intern Med J Thai 2005;21:195-202.
Liu J, Grundy SM, Wang W, Smith SC Jr, Vega GL, Wu Z, Zeng Z, et al. Ethnic-specific criteria for the metabolic syndrome.
Diabetes Care 2006;29:933-4.
Park HS, Lee SY, Kim SM, Han JH, Kim DJ. Prevalance of the metabolic syndrome among Korean adults according to the criteria of the international diabetes Federation. Diabetes Care 2006;29:933-4.
Wilson PWF, D'Augustino RB, Parise H, Sullivan L, Meigs JB. Metabolic syndrome as a precursor of cardiovascular disease and
type 2 diabetes mellitus, Circulation 2005;112:3066-72.
Sone H, Mizuno S, Fujii H, Yoshimura Y, Yamasaki Y, Ishibashi S, et al. Is the diagnosis of metabolic syndrome useful for predicting cardiovascular disease in Asian diabetic patients?. Diabetes Care 2005;28:1463-71.
Sundstrom J, Vallhagen E, Riserus U, Byberg L, Zethelius B, et al. Risk associated with the metabolic syndrome versus the sum of its individual components. Diabetes Care 2006; 29:1673-4.
Ravaglia G, Forti P, Maioli F, Bastagli L, Chiappelli M, et al. Metabolic syndrome : prevalence and prediction of mortalilty in elderly individuals. Diabetes Care 2006;29:2471-76.
Lorenzo C, Williams K, Hunt KJ, Haffner SM. TheNational Cholesterol Education Program-Adult Treatment Panel III, International Diabetes Federation, and World Health Organization definitions of the metabolic syndrome as predictors of incident of cardiovascular disease and diabetes. Diabetes Care 2007;30:8-13.
Kahn R, Buse J, Ferrannini E, Stern M. The metabolic syndrome: time for a critical appraisal: Joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 2005;28:2289-2304.
The Metascreen Writing Committee. The metabolic sysdrome is a risk indicator of microvascular and macrovascular complications in diabetes. Diabetes Care 2006;29:2701-7.
Selvin E, Marinopoulos S, Berkenblit G, Rami T, Brancati FL, Powe NR, Gloden SH. Meta-analysis:
glycosylated hemoglobin and cardiovascular disease in diabetes mellitus. Ann Intern Med 2004;141:421-34.